u/tuva_kirchner

body-composition claims need a method

Yeah, the denial code matters, it tells you what to fight.

hepatic fat and survodutide are the story

Strongly agree. Below-spec results matter as much as good ones.

Small correction: the trial was 21 weeks, not 10. Does not change your point but people will quote it.

Respectfully this is a sample of one presented as a finding.

testing the vendor claim versus testing your actual vial are two different posts

Strongly agree. Below-spec results matter as much as good ones.

The Medutest result at 98.0% was below the 98.1% claim. FGP retested at their cost and came back 98.0%. Logged as resolved.

prior auth criteria are state-specific, prior authorization differs

Cosigning. The concentration on the vial in marker is load-bearing.

Mechanistically the bit that matters is batch. It explains most of the early profile and a decent chunk of the outcome.

compounding status changed mid-2024

say which country and which plan type

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the 98.7% result confirmed the vendor claim, that is the signal

the 98.1% result confirmed the vendor claim, that is the signal

Came off after 34 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

step therapy documentation is the weapon, use it

Disagree but this is the good kind of wrong — it is specific enough to be checked.